General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study

General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study

Principles: Chronic obstructive pulmonary disease (COPD) is a major burden on patients and healthcare systems. Diagnosis and the management of COPD are often administered by general practitioners (GPs). This analysis investigated the adherence of GPs in Switzerland to the Global Initiative for Ch...

Full description

Bibliographic Details
Main Authors:	A Jochmann, F Neubauer, D Miedinger, PN Chhajed, Török Schafroth
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2010-08-01
Series:	Swiss Medical Weekly
Subjects:	bronchodilators COPD GOLD Guidelines inhaled corticosteroids management
Online Access:	https://www.smw.ch/index.php/smw/article/view/1164

Similar Items

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
by: Anja Jochmann, et al.
Published: (2012-03-01)

General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study
by: S Schafroth
Published: (2010-04-01)

Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort
by: Veronika Mangold, et al.
Published: (2023-10-01)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
by: Marc Miravitlles, et al.
Published: (2022-11-01)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)

Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
by: Sun Hye Shin, et al.
Published: (2020-08-01)

Pharmacological Treatment in Asthma and COPD
by: Tomoaki Hoshino, et al.
Published: (2009-01-01)

The adjusted impact of different severities of acute exacerbations and medications on the risk of developing dementia in COPD patients
by: Kuo-Hua Chia, et al.
Published: (2023-03-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Adherence to the Swiss guidelines for management of COPD: Experience of a Swiss teaching hospital
by: K Fritsch, et al.
Published: (2005-02-01)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
by: Rosario Lineros, et al.
Published: (2023-04-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
by: Trigueros JA, et al.
Published: (2022-11-01)

The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
by: Millares L, et al.
Published: (2022-08-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
by: Peter M. A. Calverley, et al.
Published: (2021-06-01)

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications
by: Ding B, et al.
Published: (2017-05-01)

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
by: Ferguson GT, et al.
Published: (2016-10-01)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
by: Barbara Bonnesen, et al.
Published: (2022-06-01)

Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
by: Samy Suissa, et al.
Published: (2022-12-01)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
by: Paul D. Terry, et al.
Published: (2023-07-01)

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
by: Cataldo D, et al.
Published: (2017-02-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
by: Varvara Boryushkina, et al.
Published: (2020-07-01)

Challenging case of severe acute asthma in a mechanically ventilated patient managed with sevoflurane
by: Satheesh Munusamy, et al.
Published: (2023-02-01)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
by: Grace Oscullo, et al.
Published: (2023-10-01)

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
by: Hyunji Jo, et al.
Published: (2022-04-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)

The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
by: Ichinose M, et al.
Published: (2016-08-01)

Serum periostin does not reflect type 2-driven inflammation in COPD
by: O. A. Carpaij, et al.
Published: (2018-06-01)

Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary
by: Amnon Ariel, et al.
Published: (2023-11-01)

Mapping of Modifiable Factors with Interdisciplinary Chronic Obstructive Pulmonary Disease (COPD) Guidelines Adherence to the Theoretical Domains Framework: A Systematic Review
by: Issac H, et al.
Published: (2022-01-01)

The Management of Acute Exacerbations in COPD: A Retrospective Observational Study and Clinical Audit
by: Maria Boesing, et al.
Published: (2023-12-01)

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
by: Turégano-Yedro M, et al.
Published: (2023-12-01)

Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study
by: Posthuma R, et al.
Published: (2023-06-01)

Evaluation of Inhaler Technique In COPD And Asthma Patients
by: Mohammed Hussein Abdulredha, et al.
Published: (2023-06-01)

Predictors of Single Bronchodilation Treatment Response for COPD: An Observational Study with the Trace Database Cohort
by: Laura Carrasco Hernández, et al.
Published: (2021-04-01)